UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer

January 19, 2018

Responsive image

BRISTOL, Tenn., Jan. 19, 2018 /PRNewswire/ — UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on solid oral and semi-solid dosage forms, has appointed Chris Curtin as Chief Operating Officer. Mr. Curtin was promoted from his previous role as…

Category: Precious Metals